Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
It is a randomized clinical phase II treatment trial studying PRIM-DJ2727 or placebo in adult patients with Non-Alcoholic Fatty Liver Disease (NAFLD) / Metabolic dysfunction-associated fatty liver disease (MAFLD) and history of diabetes mellitus
Microbiome Diversity in Fecal Samples as Indicated by the Shannon Diversity Index
The study was withdrawn
…